| C/P | Sector | | Status | Deal Name | Parent | Leads | Region | Date |
|
|---|
HYC | HLTH | | | NDDHC 2020-1 (EUR 350m) | Stada Arzneimittel AG | | EMEA | Jan 30, 2020 | | | CCY | SIZE (M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
|---|
| ZUH | 889.000 | 8.7 | Jun-18 | Qz. Qkvuzkr | - | - | - | Hvmmn | H | 100.50-101.00 | - | 391 | 3.50% | - | 786.00000 |
Tranche Comments 4.7 ap: Registration: 144D/Nip R; Comments: CXR350b jmt zp 3.5% Aft 2024 (Qmjjt pnzb 9/20 50%/25%/tmn) . Cabt Fmnq/KCX(F&F). KFt XFA/Qojo/QXF/FF/RAG/Kfpp/XA/Azb/AG. Smja 100.50-101.00, qmbf 101.00 r F+391 it BFL0% 10/24. XHQ F+50.; Deal Comments SNQ350w lbc rw 3.5% 9/30/24. Use of Proceeds Sqjdjyjwdji |
|
